main-logo

ICD-10 Code C85.1A | Unspecified B-cell lymphoma, in remission Symptoms, Diagnosis, Billing

Unspecified B-cell lymphoma, in remission is a hematological malignancy characterized by the proliferation of B-lymphocytes. This condition is clinically significant as it indicates a previous diagnosis of B-cell lymphoma that has responded to treatment, necessitating accurate coding for effective documentation, billing, and public health reporting. The ICD-10 Code C85.1A facilitates precise diagnosis and ensures compliance with healthcare regulations.

What is ICD-10 Code C85.1A for Unspecified B-cell lymphoma, in remission?

ICD-10 Code C85.1A represents Unspecified B-cell lymphoma, in remission, indicating that the patient has a history of B-cell lymphoma that is currently not active. This code should be used in clinical documentation and billing when a patient has achieved remission, allowing for appropriate tracking of treatment outcomes and healthcare resource utilization.

ICD-10 Code C85.1A – Clinical Definition and Explanation of Unspecified B-cell lymphoma, in remission

Unspecified B-cell lymphoma, in remission, is a type of non-Hodgkin lymphoma that arises from B-cells. The condition can result from genetic mutations or environmental factors and may progress to more severe forms if not monitored. Medical attention is crucial to manage potential relapses and ensure ongoing patient health.

Key Clinical Features:

  • Presence of previous B-cell lymphoma diagnosis.
  • Evidence of remission through clinical evaluation.
  • Regular monitoring for potential relapse.
  • Management of treatment-related complications.

ICD-10 Code C85.1A for Unspecified B-cell lymphoma, in remission – SOAP Notes & Clinical Use

ICD-10 Code C85.1A is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.

What Does ICD-10 Code C85.1A for Unspecified B-cell lymphoma, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C85.1A connects subjective reports of patient history and objective clinical findings to a formal diagnosis of remission. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C85.1A – Unspecified B-cell lymphoma, in remission

Management of Unspecified B-cell lymphoma, in remission, focuses on monitoring and supportive care to prevent relapse.

Antibiotic Therapy:

  • Not applicable as this condition is not infectious.

Supportive Care:

  • Regular follow-up appointments for monitoring.
  • Symptom management for treatment-related effects.
  • Nutritional support and counseling.

Infection Control:

  • Standard precautions to prevent infections.
  • Vaccination updates as per guidelines.

How to Document Symptoms of Unspecified B-cell lymphoma, in remission (ICD-10 C85.1A) in SOAP Notes

Subjective:

  • Patient reports feeling well with no new symptoms.
  • History of previous B-cell lymphoma treatment.
  • Concerns about potential relapse.

Objective:

  • Physical examination shows no lymphadenopathy.
  • Blood tests indicate normal complete blood count.
  • Imaging studies show no signs of active disease.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Unspecified B-cell lymphoma, in remission (ICD-10 Code C85.1A)

Assessment:

  • Unspecified B-cell lymphoma, in remission (ICD-10 Code C85.1A).
  • No current signs of active disease.
  • Patient is stable with regular follow-up.

Plan:

  • Continue regular monitoring and follow-up appointments.
  • Educate patient on signs of relapse.
  • Schedule next follow-up in 3 months.

Treatment & Plan Section for ICD-10 Code C85.1A – Unspecified B-cell lymphoma, in remission

  • Regular follow-up and monitoring for relapse.
  • Patient education on symptoms of recurrence.
  • Supportive care for any treatment-related side effects.
  • Coordination with oncology for ongoing management.

Using ICD-10 Code C85.1A for Unspecified B-cell lymphoma, in remission in Billing & SOAP Note Compliance

  • Ensure accurate documentation of remission status in SOAP notes.
  • Use C85.1A in settings where the patient is monitored post-treatment.
  • Document any symptoms or concerns to support the diagnosis.
  • Align treatment plans with clinical guidelines for justified billing.

    ICD-10 Code C85.1A in Medical Billing and Insurance for Unspecified B-cell lymphoma, in remission

    ICD-10 Code C85.1A is essential for accurate billing in hospital, ER, or oncology settings.

    Billing Notes:

    • Document the patient's remission status clearly in the medical record.
    • Use this code in follow-up visits to track remission.
    • Ensure all relevant clinical findings are included in the documentation.

    Common CPT Pairings:

    CPT CodeDescription
    99213Established patient office visit, moderate complexity.
    85025Complete blood count with differential.
    36415Collection of venous blood by venipuncture.

    Frequently Asked Questions

    Common Questions About Using ICD-10 Code C85.1A for Unspecified B-cell lymphoma, in remission

    What does it mean if a patient is in remission?

    Being in remission means that the signs and symptoms of the lymphoma are not currently present, indicating a positive response to treatment. However, ongoing monitoring is essential to detect any potential relapse.

    How often should follow-up visits occur for patients in remission?

    Follow-up visits for patients in remission are typically scheduled every 3 to 6 months, depending on the patient's individual risk factors and treatment history, to monitor for any signs of recurrence.

    Can patients with this diagnosis experience symptoms?

    Patients in remission may not experience symptoms; however, they should remain vigilant for any new or returning symptoms and report them to their healthcare provider promptly.

    Is there a risk of relapse for patients in remission?

    Yes, patients in remission are at risk of relapse, which is why regular monitoring and follow-up care are crucial to ensure early detection and management of any recurrence.

    diamond-bg
    diamond-bg

    Get started with your 20 free notes

    Sign up for free
    main-logo

    AI-aided Sudsy Shorthand for ink-free practices

    support@soapsuds.io
    hipaa-logo

    Clinical Notes

    SOAP notes

    DAP notes

    AI medical notes

    © Copyright SOAPsuds 2025. All rights reserved